AI
TAK icon

Atria Investments’s Takeda Pharmaceutical TAK Stock Holding History

Atria Investments’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$264K Buy
14,232
+3,712
+35% +$65.1K ﹤0.01% 1830
2025
Q4 		$164K Buy
+10,520
New +$150K ﹤0.01% 1988
2024
Q4 		– Sell
-15,508
Closed -$221K – 1980
2024
Q3 		$221K Sell
15,508
-6,415
-29% -$91K ﹤0.01% 1779
2024
Q2 		$284K Buy
+21,923
New +$290K ﹤0.01% 1623
2020
Q1 		– Sell
-23,769
Closed -$469K – 1121
2019
Q4 		$469K Buy
+23,769
New +$455K 0.01% 814
2019
Q3 		– Sell
-22,369
Closed -$379K – 965
2019
Q2 		$379K Buy
22,369
+4,561
+26% +$83K 0.01% 661
2019
Q1 		$363K Buy
+17,808
New +$358K 0.02% 624

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return